InTech uses cookies to offer you the best online experience. By continuing to use our site, you agree to our Privacy Policy.

Medicine » Immunology, Allergology and Rheumatology » "Acute Phase Proteins as Early Non-Specific Biomarkers of Human and Veterinary Diseases", book edited by Francisco Veas, ISBN 978-953-307-873-1, Published: October 10, 2011 under CC BY 3.0 license. © The Author(s).

Chapter 2

Apolipoprotein H, an Acute Phase Protein, a Performing Tool for Ultra-Sensitive Detection and Isolation of Microorganisms from Different Origins

By Ilias Stefas, Gregor Dubois, Sylvia Tigrett, Estelle Lucarz and Francisco Veas
DOI: 10.5772/25229

  • Prof. Francisco Veas

    Update my profile »
    Dr. Francisco Veas, Ph.D. is a Viral Immuno-Physiopathologist and is currently a Research Professor at the Health Department of the French Institute for Development (IRD). He is also in charge of Comparative Molecular Immuno-Physiopathology Lab and Deputy Director of the research unit UMR-MD3-Université Montpellier 1 in Montpellier, France. Professor Veas received his PhD in Comparative Pathology in 1986 at the University Montpellier II. Between January 1987 and June 1988 he held a post-doctoral position on molecular biology of the protozoan Leishmania sp and Trypanosoma cruzi at the Research Centre on Macromolecular Biology of the centre National de la Recherche Scientifique (CNRS), Montpellier. In 1988, he was a laureate of the Fondation pour la Recherche Médicale and from July 1988 up to 1990 he served as Assistant Professor in the Parasites’ population genetics lab at the IRD in Montpellier. From 1991-1995 he was in charge of viral experimental research of the AIDS program at IRD. From 1996 to 2000, he was director of the Retroviral Immunology Lab at the IRD CNRS Unit 5087 in Montpellier. In 2000, he cofounded the ApoH-Technologies biotech spin-off of IRD. From 2001 to 2009 he was in charge of studies on viral physiopathology of HIV and Dengue virus at the IRD research Unit  “Viral Emerging Diseases Unit”. In 2009, Professor Veas has been appointed CSO of ApoH-Technologies and in 2010 has been appointed head of Comparative Molecular Immuno-Physiopathology Lab at the Unit MD3 which he co-directs. From 1998, different French institutions, including Foundation pour la Recherche Médicale, SIDACTION, ANRS, CNRS, IRD, Region Languedoc Roussillon, have been supporting and funding his research. Recently, he was promoter, member of the executive board and reporter of the USDEP European Project (Ultrasensitive detection of emerging pathogens, 2006-2010). Professor Veas has also created several technological platforms including sequencing, high biosafety labs (BSL2 and BSL3), proteomics, etc. His scientific activities and publication and patents have been mainly dedicated to conserved aspects of host and pathogens including innate immunity, viral physiopathology, vaccines and diagnostics.